[Hypophosphatemia, a poorly known adverse reaction of intravenous use of iron]

Med Clin (Barc). 2014 Sep 15;143(6):284-5. doi: 10.1016/j.medcli.2013.11.030. Epub 2014 Jan 22.

[Article in Spanish]

Authors

Jesús Abelardo Barea Mendoza¹, Iñigo Gredilla Zubiría², Jesús González Olmedo², Salvador Mateo Alvarez²

Affiliations

¹ Servicio de Medicina Intensiva, Hospital 12 de Octubre, Madrid, España. Electronic address: elbarea@gmail.com.
² Servicio de Medicina Interna, Hospital 12 de Octubre, Madrid, España.

PMID: 24461741
DOI: 10.1016/j.medcli.2013.11.030

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Anemia, Iron-Deficiency / blood
Anemia, Iron-Deficiency / complications
Anemia, Iron-Deficiency / drug therapy*
Causality
Diabetes Mellitus, Type 2 / blood
Diabetes Mellitus, Type 2 / complications
Ferric Compounds / administration & dosage
Ferric Compounds / adverse effects*
Ferric Compounds / therapeutic use
Fibroblast Growth Factor-23
Fibroblast Growth Factors / physiology
Hepatitis C, Chronic / blood
Hepatitis C, Chronic / complications
Humans
Hypocalcemia / chemically induced
Hypophosphatemia / chemically induced*
Infusions, Intravenous
Male
Maltose / administration & dosage
Maltose / adverse effects
Maltose / analogs & derivatives*
Maltose / therapeutic use

Substances

Ferric Compounds
Fibroblast Growth Factors
ferric carboxymaltose
Maltose
Fibroblast Growth Factor-23